MedSim and Sonus eye contrast training
Ultrasound training simulator developer MedSim of Kfar-Sava, Israel, and contrast agent firm Sonus Pharmaceuticals of Bothell, WA, have agreed to jointly develop a training program that will help physicians learn to use ultrasound contrast more
Ultrasound training simulator developer MedSim of Kfar-Sava, Israel, and contrast agent firm Sonus Pharmaceuticals of Bothell, WA, have agreed to jointly develop a training program that will help physicians learn to use ultrasound contrast more effectively. The two companies are planning to develop a contrast module that will run on MedSim's UltraSim ultrasound training simulator (SCAN Special Report 4/97).
UltraSim enables users to conduct virtual ultrasound exams by scanning a mannequin and accessing ultrasound data stored on CD-ROM that correspond to the area being examined. Sonus hopes an UltraSim contrast module will help the company train large numbers of physicians in the use of its EchoGen contrast agent for echocardiography. The companies plan to conduct a feasibility study on the module at a major U.S. ultrasound teaching institution.
New MRI Research Explores Links Between Waist-to-Hip Ratio and Memory in Aging
March 13th 2025Researchers found that a higher waist-to-hip ratio in midlife was associated with higher mean diffusivity in 26 percent of total white matter tracts in the cingulum as well as the superior and inferior longitudinal fasciculus.
Can Ultrasound-Based Radiomics Enhance Differentiation of HER2 Breast Cancer?
March 11th 2025Multicenter research revealed that a combined model of clinical factors and ultrasound-based radiomics exhibited greater than a 23 percent higher per patient-level accuracy rate for identifying HER2 breast cancer than a clinical model.
